Impax Laboratories State Court Decisions

IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al

Filed: May 9, 2017

State: New Jersey
Court: New Jersey District Court
Case Number: 2:2015cv06934

OPINION/ORDER re: construction of claims in U.S. Patent No. 8,377,474 (the 474 patent). Signed by Judge Stanley R. Chesler on 5/9/17. (DD, )

Impax Laboratories Inc. et al v. Lannett Holdings Inc. et al

Filed: March 29, 2017

State: Delaware
Court: Delaware District Court
Case Number: 1:2014cv00984

TRIAL OPINION. Defendants have failed to prove the Dearn patents are invalid. If desired, Defendants should request an opportunity to cross-examine Ms. Allen within one week. If Defendants do not make that request, the parties should submit an agreed upon form of final judgment within two weeks. Signed by Judge Richard G. Andrews on 3/29/2017. (nms)

Impax Laboratories, Inc. v. Turing Pharmaceuticals AG

Filed: November 16, 2016

State: New York
Court: New York Southern District Court
Case Number: 1:2016cv03241

OPINION AND ORDER. For the foregoing reasons, Defendant's motion to dismiss with prejudice Plaintiff's unjust enrichment claim (Count V of the Amended Complaint) is GRANTED. Plaintiff's motion for oral argument is DENIED as moot. The C lerk of the Court is respectfully directed to terminate the motions, Doc. 60 & 65. It is SO ORDERED. re: 60 MOTION to Dismiss Plaintiff's Unjust Enrichment Claim. filed by Turing Pharmaceuticals AG, 65 LETTER MOTION for Oral Argument…

ENDO PHARMACEUTICALS INC. v. IMPAX LABORATORIES, INC.

Filed: October 25, 2016

State: New Jersey
Court: New Jersey District Court
Case Number: 2:2016cv02526

OPINION. Signed by Judge Jose L. Linares on 10/25/16. (DD, )

IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al

Filed: May 27, 2016

State: New Jersey
Court: New Jersey District Court
Case Number: 2:2015cv06934

OPINION/ORDER granting in part and denying in part 43 Motion to Stay; that Impax shall provide the Court with status updates regarding the ex parte reexamination of U.S. Patent No. 7,094,427, every sixty (60) days starting June 17, 2016; that Impax shall notify the Court within ten (10) days of any disposition of the ex parte reexamination of U.S. Patent No. 7,094,427. Signed by Judge Stanley R. Chesler on 5/26/16. (DD, )

linus Aruliah v. Impax Laboratories, Inc. et al

Filed: December 21, 2015

State: California
Court: California Northern District Court
Case Number: 3:2014cv03673

ORDER APPROVING SETTLEMENT AND FINAL JUDGMENT signed by Hon. James Donato on December 21, 2015. (jdlc1S, COURT STAFF) (Filed on 12/21/2015)

Impax Laboratories Inc. et al v. Lannett Holdings Inc. et al

Filed: December 1, 2015

State: Delaware
Court: Delaware District Court
Case Number: 1:2014cv00984

MEMORANDUM OPINION providing claim construction for disputed terms in U.S. Patent Nos. 6,750,237 and 7,220,767. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion. Signed by Judge Richard G. Andrews on 12/1/2015. (nms)